CARISMA Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, Oct. 5, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual investor conferences in October 2020.

• Chardan 4th Annual Genetic Medicines Conference
  Tuesday, October 6, 2020 at 11:00 am EST

• 7th Solebury Trout Private Company Showcase Co-Hosted by BMO and Davis Polk
  Thursday, October 15, 2020 at 10:40 am EST

About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

For more information, please visit www.carismatx.com

Media Contact:
Christina Khoury-Folkens
612-806-0757
[email protected] 

SOURCE CARISMA Therapeutics Inc.